Friday , May 24 2019
Home / chile / The meningitis vaccine divides the public health

The meningitis vaccine divides the public health


Vaccine against Meningitis Divides the Spanish public health. Autonomous communities Canary Islands and Castilla y León They had already decided to fund it with public money Andalusia It intends to "combine it, if possible, by the year 2020 or 2021," as announced by the Council of Health and Families Board, Jesús Aguirre. However, other areas, such as the Ministry of Health, have removed this vaccine from public funding, which for private individuals may assume Spending about 400 euros And is applied by three doses in the first 12 months of newborn life.

God Public Health CommitteeMinistry of Health offices of various autonomous communities meet, gave a green light last Thursday to the inclusion of Tetravalent vaccine Which protects the 12-year-olds A, C, W and Y. But it remains B, which has infants as one of its main goals.

As the ministry justifies, the position against general vaccination against meningitis B has been adopted "taking into account Epidemiological condition Current, along with available information on the vaccine, which shows short duration of protection after vaccination, lack of protection in the population without shortage, lack of high efficacy data and reactogenicity when administered together with vaccines from the diary at the childhood stage.

Version of those affected

In light of the technical criteria of most of the members of the public health committee, groups of patients who are affected and children are located. God Spanish Association Against Meningitis He sees progress with positive tetravalent, but then asks: "What do we say to parents who lose a child due to meningitis B in the coming months …?"

of Spanish Children's Association (AEP) is also applauded for the public funding of tetravalent, but at the same time a special "fatal virulence" of all meningitis in the early years of life, including Type B, recalled. Doctor Federico Martion-Torres, Head of the Children's Service of the Clinical Hospital of the University of Santiago de Compostela, "Spanish vaccination policy against maningococcus is not enough," he adds, «Safer than sorry».

Critics blame the Health Ministry's decision to fund reasons. In fact, AEP recommends a maningococcal B vaccine From 3 months.


Meningitis B is a disease that causes Spain 300 infections per year, Of which about 10% are fatal and another 20% cause serious physical consequences, including amputation of legs or arms, blindness or deafness. It is a very low fire but has serious consequences, especially in infants. That the cost of vaccination reaches 400 euros for people involved, as emphasized by the Spanish Association against Meningitis, the danger that meningitis B is due to a factor of Social inequality, By affecting the poorest regions.

More info

Source link